What are the clinical features of HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome in pregnant women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Features of HELLP Syndrome

HELLP syndrome presents with a characteristic triad of hemolysis, elevated liver enzymes, and low platelet count (<100,000/mm³), occurring in 0.2-0.6% of pregnancies, typically in the third trimester or within 48 hours postpartum, with preeclampsia present in 95% of cases. 1, 2

Cardinal Symptoms and Signs

Abdominal and Gastrointestinal Manifestations

  • Abdominal pain occurs in 65% of cases, specifically right upper quadrant or epigastric pain resulting from liver capsule distension due to hepatic edema and subcapsular hemorrhage 2, 3
  • Nausea and vomiting are present in 65% of patients 2
  • This abdominal pain should immediately trigger suspicion for HELLP syndrome regardless of whether classic preeclampsia signs are present 3

Preeclampsia-Associated Features

  • Hypertension (BP ≥140/90 mmHg) and proteinuria are present in 95% of HELLP cases 2
  • Severe headache and visual disturbances are common neurological symptoms 2
  • Peripheral edema is frequently observed 1

Timing and Demographics

  • Onset typically occurs in the third trimester or within 48 hours postpartum 1, 2
  • More frequent in older multiparous women aged >35 years 1, 4
  • Can rarely develop in the second trimester 5

Laboratory Abnormalities

Hematologic Findings

  • Thrombocytopenia with platelet count <100,000/mm³ (often <100×10⁹/L) is a diagnostic requirement 1, 2, 6
  • Peripheral blood smear showing schistocytes indicating microangiopathic hemolytic anemia 7
  • Elevated lactate dehydrogenase (LDH) reflecting both hemolysis and hepatocellular damage 1, 3
  • Decreased haptoglobin levels 6
  • Elevated indirect bilirubin (typically <5 mg/dL) 1

Hepatic Dysfunction

  • Elevated liver enzymes with ALT typically <500 U/L 1, 2
  • AST elevation (can be >135 U/L in severe cases) 7
  • The degree of liver enzyme elevation correlates with disease severity 3

Coagulation Abnormalities

  • Disseminated intravascular coagulation (DIC) occurs in 29% of cases requiring intensive care 8
  • Elevated international normalized ratio (INR) in severe cases 8
  • Prolonged prothrombin time (PT) 1

Renal Involvement

  • Elevated uric acid levels 1
  • Proteinuria (≥0.3 g/24 hours) 1
  • Elevated serum creatinine in severe cases 1

Imaging Findings

  • Hepatic infarcts, hematoma, or rupture are possible complications 1, 2
  • No ascites typically present (distinguishing feature from acute fatty liver of pregnancy) 1, 2
  • Abdominal ultrasound is mandatory if symptoms suggest hepatic hematoma, particularly with severe thrombocytopenia and persistent right upper quadrant pain 7, 3

Critical Complications and Severity Markers

Maternal Complications

  • Acute renal failure occurs in 25% of ICU admissions 8
  • Postpartum hemorrhage in 21% of severe cases 8
  • Seizures (progression to eclampsia) 1
  • Hepatic rupture (rare but life-threatening) 1, 7
  • Maternal mortality rate 1-25% (1% in general population, up to 14% in ICU admissions) 1, 8

Severity Predictors

  • Higher mortality risk associated with: elevated INR, higher AST/ALT/LDH levels, higher bilirubin, and lower platelet counts 8
  • DIC is a major risk factor for adverse maternal outcome 8
  • Severe thrombocytopenia with platelets <50,000/mm³ indicates need for platelet transfusion before cesarean section 7

Fetal/Perinatal Outcomes

  • Fetal mortality rate 7-20% (perinatal mortality 11-30% in severe cases) 1, 2, 8
  • Increased risk of fetal growth restriction and fetal demise 1

Key Diagnostic Pitfalls

  • HELLP syndrome can occur without classic preeclampsia symptoms in 5% of cases, making diagnosis challenging 2
  • The syndrome may be confused with acute fatty liver of pregnancy, idiopathic thrombocytopenia, hemolytic uremic syndrome, or appendicitis 5
  • Symptoms can develop postpartum (within 48-72 hours after delivery), requiring continued vigilance 5
  • Regional anesthesia should not be used with platelets <100,000/mm³ or elevated INR due to epidural hematoma risk 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Differential Diagnosis: HELLP Syndrome vs. Acute Fatty Liver of Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pre-eclampsia/Eclampsia Pathophysiology and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

HELLP syndrome--a pregnancy disorder with poor prognosis.

Nepal Medical College journal : NMCJ, 2008

Guideline

Diagnosis and Management of HELLP Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What are the diagnostic criteria for Hellp (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome?
Can HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome present with an increased International Normalized Ratio (INR) and ascites?
What is the management for a postpartum patient developing symptoms of HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome without prior pre-eclampsia or HELLP syndrome?
What are the diagnosis and treatment of HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome?
What are the diagnostic criteria and management for HELLP (Hemolysis, Elevated Liver enzymes, and Low Platelet count) syndrome?
Is my NSAID (Non-Steroidal Anti-Inflammatory Drug) induced gastritis considered healed after 3.5 weeks of treatment with a medication, now that I've started tapering off and no longer experience symptoms like bloating and sourness?
Should I delay starting statin (HMG-CoA reductase inhibitor) therapy in a patient with hypertension, smoking history, and likely hyperlipidemia until I obtain their lipid profile to calculate their Atherosclerotic Cardiovascular Disease (ASCVD) risk?
What is the management approach for a patient with suspected battery ingestion?
What is the management approach for a patient with abnormal serum calcium and magnesium levels?
What is the recommended dose and administration frequency of budesonide for a patient undergoing nebulization therapy?
Can a blood pressure cuff be prescribed as Durable Medical Equipment (DME) for a patient with hypertension, a history of smoking, and likely hyperlipidemia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.